Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 4Phase 1/2 4Phase 1 3Phase 3 1

Status

Unknown 3Completed 3Recruiting 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Electroporation × Clear all
NCT04612530 2022-12-20

PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer

Amsterdam UMC, location VUmc

Phase 1 Unknown
18 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04139070 2020-08-20

Electrochemotherapy for Non-curable Gastric Cancer

Zealand University Hospital

Phase 1 Unknown
8 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03051269 2017-02-13

Calcium Electroporation for Head and Neck Cancer

Rigshospitalet, Denmark

Phase 1 Unknown
6 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡